source
- AstraZeneca halts several mid- and late-stage trials after efficacy setbacksAstraZeneca announced it has stopped a number of mid- and late-stage clinical trials in its pipeline over recent months. The decision follows disappointing efficacy results in those studies, limit…
- FDA moves to speed trials by reviewing AstraZeneca and Amgen data in real time, seeks public input on pilot programThe U.S. Food and Drug Administration announced a new initiative aimed at making clinical trials faster and more efficient. As a first step, the agency will begin reviewing trial data in real time…